# Rezolute, Inc. (RZLT)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RZLT/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -16.17M | $ -13.74M | $ 1.11M | $ 116.83M |
| 2025 | $ 0 | $ -86.24M | $ -78.99M | $ 1.29M | $ 128.00M |
| 2024 | $ 0 | $ -74.77M | $ -66.68M | $ 1.93M | $ 99.59M |
| 2023 | $ 0 | $ -61.45M | $ -57.15M | $ 2.51M | $ 91.73M |
| 2022 | $ 0 | $ -49.17M | $ -46.15M | $ 2.36M | $ 141.27M |
| 2021 | $ 0 | $ -36.39M | $ -28.72M | $ 14.46M | $ 62.27M |
| 2020 | $ 0 | $ -24.59M | $ -24.93M | $ 597.0K | $ 35.89M |
| 2019 | $ 0 | $ -44.74M | $ -34.44M | $ 526.0K | $ 14.69M |
| 2018 | $ 25.94M | $ -33.00M | $ -12.08M | $ 5.02M | $ -9.79M |
| 2017 | $ 0 | $ -32.30M | $ -20.81M | $ 10.0K | $ 3.80M |
| 2016 | $ 0 | $ -22.41M | $ -17.69M | $ 10.0K | $ 7.93M |
| 2015 | $ 0 | $ -19.05M | $ -17.93M | $ 130.5K | $ 3.78M |
| 2014 | $ 0 | $ -17.30M | $ -9.05M | $ 222.5K | $ 7.82M |
| 2013 | $ 0 | $ -11.66M | $ -3.54M | $ 4.80M | $ -4.40M |
| 2012 | $ 0 | $ -76.4K | $ -58.1K | $ 15.9K | $ -24.5K |
| 2011 | $ 0 | $ -22.6K | $ -31.1K | $ 0 | $ 10.0K |
| 2010 | $ 0 | $ -2.7K | N/A | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.07 |
| Current Ratio | 15.84 |

## Other views

- [Metrics](https://sponda.capital/en/RZLT.md)
- [Charts](https://sponda.capital/en/RZLT/charts.md)
- [Compare](https://sponda.capital/en/RZLT/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.